University Hospital Ventures
VC Fund
Cleveland, United States
University Hospital Ventures is a VC fund in Cleveland focused on Health Care and Medical. University Hospital Ventures is the venture arm of University Hospitals. UH Ventures is solving for the future of University Hospitals and the future of healthcare. We identify, develop, and deploy the most disruptive and creative innovations that originate from within University Hospitals as well as from organizations all over the world.
- Total investments:
- 10
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries University Hospital Ventures invests in
Stages University Hospital Ventures invests in
Countries University Hospital Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
|
|||
Investment Focus
Industry
- Health Care 6 (60%)
- Medical 2 (20%)
- Software 2 (20%)
- Wellness 2 (20%)
- FinTech 1 (10%)
Stage
- Series B 3 (30%)
- Venture - Series Unknown 3 (30%)
- Seed 1 (10%)
- Pre-Seed 1 (10%)
- Series A 1 (10%)
Country
- United States 6 (60%)
- Israel 1 (10%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Neil Wyant
Managing Director, UH Ventures
|
Managing Director, UH Ventures | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
TandemStride provides genuine, individualized support to survivors and their loved ones, whether in the form of a peer mentor with training, resources, or just someone who knows what it's like to be in recovery. | $5.5M / Seed / Sep 08, 2025 | |
|
|
TailorMed is a health IT company that works with providers, pharmacies and manufacturers to reduce patient financial toxicity and create efficiencies across the patient treatment lifecycle. Our end-to-end platform applies algorithms and automations to make the co-pay assistance and free drug order processes seamless and leverages our deep data setto create actionable insights. | $27.5M / Series B / Nov 21, 2024 | |
|
|
Axuall is a workforce intelligence company built on a national real-time practitioner data network. Axuall offers a holistic approach to workforce analytics, including an integrated platform for driving smarter decisions and quickly onboarding providers. It enables healthcare systems, staffing firms, telehealth, and health plans to reduceonboarding and enrollment time while also providing unique, powerful data insights for network planning, analytics, and reporting. | $20M / Series B / May 31, 2023 | |
|
|
TailorMed is a health IT company that works with providers, pharmacies and manufacturers to reduce patient financial toxicity and create efficiencies across the patient treatment lifecycle. Our end-to-end platform applies algorithms and automations to make the co-pay assistance and free drug order processes seamless and leverages our deep data setto create actionable insights. | Venture - Series Unknown / Dec 19, 2022 | |
|
|
Lazurite is a pre-revenue medical device startup company backed by private capital. The company has raised approximately $18 million to date from institutional investors, high-net worth individuals, and more than 50 physician champions. Lazurite has developed novel technology that will enable it to create the operating room of the future. Thecompany’s product pipeline features the ArthroFree™ wireless camera system, the world’s first fully wireless minimally invasive camera system platform designed for the operating room; ORFree™, the world’s first fully wireless mobile minimally invasive surgical camera platform; and others based on the company’s novel and patented Meridiem™ light engine technology. | Venture - Series Unknown / Feb 22, 2022 | |
|
|
Renalis is a digital health company that develop platforms to improve experiences and outcomes for people with pelvic health conditions. Designed to tackle the challenges in pelvic health management, Renalis platforms increase patient engagement, improve adherence, decrease out-migration, saving providers valuable time and effort. | $824K / Pre-Seed / Sep 01, 2021 | |
|
|
Axuall is a workforce intelligence company built on a national real-time practitioner data network. Axuall offers a holistic approach to workforce analytics, including an integrated platform for driving smarter decisions and quickly onboarding providers. It enables healthcare systems, staffing firms, telehealth, and health plans to reduceonboarding and enrollment time while also providing unique, powerful data insights for network planning, analytics, and reporting. | $10.4M / Series A / Jul 01, 2021 | |
|
|
Conversa enables health systems to virtually engage, monitor and manage patients for chronic care, acute discharge, perioperative, oncology, OBGYN, prevention and wellness, and more. The automated care platform engages patients at high frequency and scale, while triaging to care venues when necessary, optimizing and improving the use of telehealthe-visits, phone calls and in-person consults. Conversa’s suite of COVID-19 Virtual Care Programs is being used by innovative organizations like UCSF Health, Northwell, UNC Health, Prisma Health and University Hospitals to provide symptom checking and triage, provide check-ins with quarantined patients, deliver lab results and screen employees, patients and visitors. | $8M / Series B / Jan 19, 2021 | |
|
|
RoundTrip is disrupting the medical transportation industry by providing on-demand medical transportation for hospitals, healthcare organizations, transportation organizations, and health plans.They get the ins and outs of care coordination because they started as paramedics and EMTs before earning MBAs and executive positions at some of thelargest healthcare and medical transportation companies in the world. RoundTrip schedules, dispatches, and monitors non-emergency transportation for organizations and their riders in ten states. A few of their major partners include Mount Sinai Health System, Cooper University Health System, MD Anderson Cancer Center at Cooper, Nemours Children’s Hospital, Crozer-Keystone Health System, and GRTC (the government paratransit program) of Richmond and Henrico Counties, VA. It offers easy-to-use online and mobile platforms that connect patients with non-emergency medical transportation (NEMT). | $4M / Venture - Series Unknown / Jul 21, 2020 | |
|
|
Conversa enables health systems to virtually engage, monitor and manage patients for chronic care, acute discharge, perioperative, oncology, OBGYN, prevention and wellness, and more. The automated care platform engages patients at high frequency and scale, while triaging to care venues when necessary, optimizing and improving the use of telehealthe-visits, phone calls and in-person consults. Conversa’s suite of COVID-19 Virtual Care Programs is being used by innovative organizations like UCSF Health, Northwell, UNC Health, Prisma Health and University Hospitals to provide symptom checking and triage, provide check-ins with quarantined patients, deliver lab results and screen employees, patients and visitors. | $12M / Series B / Jun 11, 2020 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does University Hospital Ventures invest in?
University Hospital Ventures invests primarily in Health Care, Medical and Software startups, most often at Series B and Venture - Series Unknown stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact University Hospital Ventures?
Public channels for University Hospital Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at University Hospital Ventures?
The team at University Hospital Ventures includes Neil Wyant (Managing Director, UH Ventures). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!